Active substance
MOSUNETUZUMAB
Therapeutical formulation
OPLOSSING

€ 299.75 € 299.75 excluding delivery costs.

This drug is not covered by your health insurance company.

Own risk

Nothing will be charged to your deductible.

Strength
1MG/ML
Supplier
ROCHE NEDERLAND BV
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
EU number
EU/1/22/1649/001